Lunella streamlines sleep apnea diagnosis

 - 
Friday, April 3, 2020

PETERBOROUGH, N.H. – The newly launched Lunella could serve as a good referral source for HME companies providing CPAP devices, says CEO Bob Wilkins.

The company launched in March to provide home sleep testing to the more than 30 million Americans with undiagnosed obstructive sleep apnea.

“We’re not in the space of selling CPAP machines,” said Bob Wilkins, who is also CEO of SoClean. “We’re in the space of creating awareness and that’s a good thing for them and their businesses.”

SoClean announced late last year that it had the exclusive rights to market and sell Itamar Medical’s WatchPAT ONE, a single-use home sleep test.

Lunella was launched to marry the WatchPAT ONE, which is worn like a wristwatch and connects to a patch on the chest, with a network of board-certified sleep physicians to streamline getting people tested, reviewed and prescribed treatment like CPAP therapy, if needed.

“Just having a device is not a solution,” Wilkins said. “You need a way to get someone through to the prescription.”

Wilkins considers SoClean a “technology marketing company” and like he did with that company he plans a “significant investment in TV advertising” for Lunella in 2020.

Lunella will continue to improve its end-to-end service by creating a network of partners to provide whatever prescribed therapy is needed, Wilkins says.

“We’re agnostic as to who sells the equipment at the end of the day,” he said. “We want to be the lead base.”